These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457 [TBL] [Abstract][Full Text] [Related]
25. Percutaneous local ablation therapy in small hepatocellular carcinoma. Lin SM; Lin DY Chang Gung Med J; 2003 May; 26(5):308-14. PubMed ID: 12934846 [TBL] [Abstract][Full Text] [Related]
27. The truth about radiofrequency ablation and laparoscopic liver resection. Abdalla EK Ann Surg; 2011 Apr; 253(4):841-2; author reply 842-3. PubMed ID: 21475034 [No Abstract] [Full Text] [Related]
29. Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma. Kalra N; Kang M; Duseja AK; Bhatia A; Singh V; Dhiman RK; Rajwanshi A; Chawla YK; Khandelwal N Indian J Med Res; 2017 Nov; 146(Suppl):S30-S37. PubMed ID: 29578192 [TBL] [Abstract][Full Text] [Related]
30. Chemical ablation of hepatocellular carcinoma. Clark TW; Soulen MC J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S245-52. PubMed ID: 12354842 [TBL] [Abstract][Full Text] [Related]
31. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Vallone P; Catalano O; Izzo F; Siani A Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626 [TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC Gastroenterology; 2004 Dec; 127(6):1714-23. PubMed ID: 15578509 [TBL] [Abstract][Full Text] [Related]
33. Research advancement in local ablation therapy for liver cancer. Zheng YB; Zheng Y Ai Zheng; 2009 Nov; 28(11):1219-24. PubMed ID: 19895746 [TBL] [Abstract][Full Text] [Related]
34. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386 [TBL] [Abstract][Full Text] [Related]
35. Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma. Kurokohchi K; Watanabe S; Masaki T; Hosomi N; Miyauchi Y; Himoto T; Kimura Y; Nakai S; Deguchi A; Yoneyama H; Yoshida S; Kuriyama S World J Gastroenterol; 2005 Mar; 11(10):1426-32. PubMed ID: 15770716 [TBL] [Abstract][Full Text] [Related]
36. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Ohnishi K Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1254-8. PubMed ID: 9730384 [TBL] [Abstract][Full Text] [Related]
37. Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm. Shen A; Zhang H; Tang C; Chen Y; Wang Y; Zhang C; Wu Z J Gastroenterol Hepatol; 2013 May; 28(5):793-800. PubMed ID: 23432154 [TBL] [Abstract][Full Text] [Related]
38. Percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC). Mueller PR Jpn J Cancer Res; 1995 Nov; 86(11):inside front cover. PubMed ID: 8567388 [No Abstract] [Full Text] [Related]
39. Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection. Wakui N; Iida K; Ikehara T; Takayama R; Shiozawa K; Takahashi M; Nagai H; Watanabe M; Ishii K; Igarashi Y; Sumino Y Hepatogastroenterology; 2010; 57(98):195-201. PubMed ID: 20583411 [TBL] [Abstract][Full Text] [Related]